TNF-α/IFN-γ-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling

GLIA

Volumn 55, Issue 2, 2007, Pages 214-223

  Hsiao, Han Yun ^a   Mak, Oi Tong ^a   Yang, Chung Shi ^b,c   Liu, Yu Peng ^a   Fang, Kuan Ming ^a   Tzeng, Shun Fen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Calcium; cAMP; IFN ; Inducible nitric oxide synthase; p38MAPK; Proinflammatory mediators; Prostaglandin E2

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INOSITOL TRISPHOSPHATE; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CALCIUM SIGNALING; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; DINOPROSTONE; ENCEPHALITIS; ENZYME INHIBITORS; GLIOSIS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTERFERON TYPE II; INTRACELLULAR FLUID; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33845914958     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20453     Document Type: Article

References (43)

1. Aloisi F, De Simone R, Columba-Cabezas S, Levi G. 1999. Opposite effects of interferon-γ and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: A regulatory loop controlling microglia pro- and anti-inflammatory activities. J Neurosci Res 56: 571-580.
2. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391:281-285.
3. Bhat NR, Feinstein DL, Shen Q, Bhat AN. 2002. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor κB, cAMP response element-binding protein, CCAAT/enhancer-binding protein-β, and activating transcription factor-2. J Biol Chem 277:29584-29592.
4. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. 2001. Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690.
5. Caggiano AO, Kraig RP. 1999. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1β production. J Neurochem 72:565-575.
6. Calatayud S, Garcia-Zaragoza E, Hernandez C, Quintana E, Felipo V, Esplugues JV, Barrachina MD. 2002. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying. Am J Physiol Gastrointest Liver Physiol 283:G1360-G1367.
7. Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW. 2004. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: Implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 16:565-575.
8. Durieu-Trautmann O, Bourdoulous S, Roux F, Bourre JM, Strosberg AD, Couraud PO. 1993. Immortalized rat brain microvessel endothelial cells: II-Pharmacological characterization. Adv Exp Med Biol 331:205-210.
9. Eberhardt W, Pluss C, Hummel R, Pfeilschifter J. 1998. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells. J Immunol 160:4961-4969.
10. Feinstein DL, Galea E, Cermak J, Chugh P, Lyandvert L, Reis DJ. 1994. Nitric oxide synthase expression in glial cells: Suppression by tyrosine kinase inhibitors. J Neurochem 62:811-814.
11. Feinstein DL, Galea E, Reis DJ. 1993. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J Neurochem 60:1945-1948.
12. Feinstein DL, Galea E, Roberts S, Berquist H, Wang H, Reis DJ. 1994. Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 62:315-321.
13. FitzGerald GA, Patrono C. 2001. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433-442.
14. Gaillard T, Mulsch A, Klein H, Decker K. 1992. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler 373:897-902.
15. Galea E, Feinstein DL. 1999. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 13:2125-2137.
16. Gavrilyuk V, Horvath P, Weinberg G, Feinstein DL. 2001. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 78:129-140.
17. Ilzecka J. 2003. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol Scand 108:125-129.
18. Jana M, Anderson JA, Saha RN, Liu X, Pahan K. 2005. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. Free Radic Biol Med 38:655-664.
19. Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T. 1997. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 81:911-921.
20. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. 1997. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122:217-224.
21. Kitanaka J, Hashimoto H, Gotoh M, Kondo K, Sakata K, Hirasawa Y, Sawada M, Suzumura A, Marunouchi T, Matsuda T, Baba A. 1996. Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res 707:282-287.
22. Levi G, Minghetti L, Aloisi F. 1998. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80:899-904.
23. Mauel J, Ransijn A, Corradin SB, Buchmuller-Rouiller Y. 1995. Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α. J Leukoc Biol 58:217-224.
24. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
25. Minghetti L, Greco A, Cardone F, Puopolo M, Ladogana A, Almonti S, Cunningham C, Perry VH, Pocchiari M, Levi G. 2000. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J Neuropathol Exp Neurol 59:866-871.
26. Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G. 1997. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19:152-160.
27. Montine TJ, Markesbery WR, Morrow JD, Roberts LJ II. 1998. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol 44:410-413.
28. Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ II, Morrow JD. 1999. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53:1495-1498.
29. Muhl H, Kunz D, Pfeilschifter J. 1994. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol 112:1-8.
30. Murphy S. 2000. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia 29:1-13.
31. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP. 1993. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16:323-328.
32. Narumiya S. 1996. Prostanoid receptors and signal transduction. Prog Brain Res 113:231-241.
33. Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79:1193-1226.
34. Pahan K, Namboodiri AM, Sheikh FG, Smith BT, Singh I. 1997. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 272:7786-7791.
35. Pfeilschifter J, Eberhardt W, Hummel R, Kunz D, Muhl H, Nitsch D, Pluss C, Walker G. 1996. Therapeutic strategies for the inhibition of inducible nitric oxide synthase-Potential for a novel class of anti-inflammatory agents. Cell Biol Int 20:51-58.
36. Resnick DK, Nguyen P, Cechvala CF. 2001. Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. Spine J 1:432-436.
37. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20: 570-577.
38. Shie FS, Montine KS, Breyer RM, Montine TJ. 2005. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia 52:70-77.
39. Tzeng SF, Hsiao HY, Mak OT. 2005. Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr Drug Targets Inflamm Allergy 4:335-340.
40. Tzeng SF, Lee JL, Kuo JS, Yang CS, Murugan P, Ai Tai L, Chu Hwang K. 2002. Effects of malonate C60 derivatives on activated microglia. Brain Res 940(1/2):61-68.
41. Won JS, Im YB, Singh AK, Singh I. 2004. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic Biol Med 37:1834-1844.
42. Zanassi P, Paolillo M, Feliciello A, Awedimento EV, Gallo V, Schinelli S. 2001. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J Biol Chem 276:11487-11495.
43. Zhang J, Rivest S. 2001. Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem 76:855-864.